Results 191 to 200 of about 184,127 (310)

Impact of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers on the mortality in sepsis: A meta-analysis. [PDF]

World J Clin Cases, 2023
Yang DC, Xu J, Jian L, Yu Y.
europepmc   +1 more source

Empagliflozin after myocardial infarction with or without diabetes and chronic kidney disease: Insights from EMPACT‐MI

ESC Heart Failure, EarlyView.
Impact of empagliflozin in patients with and without T2D or CKD in the EMPACT‐MI trial. Baseline characteristics, HF outcomes and subgroup analysis of efficacy endpoints are shown. # Hazard ratios estimated via Cox proportional hazard model (unless indicated otherwise). ^ Rate ratios via negative binomial regression.
Francesco Fioretti, Javed Butler, Jacob A. Udell, W. Schuyler Jones, Mark C. Petrie, Josephine Harrington, Michaela Mattheus, Johann Bauersachs, Antoni Bayes‐Genis, Shaun G. Goodman, Tomasz Gasior, James L. Januzzi, Renato D. Lopes, Piotr Ponikowski, Xavier Rossello, Morten Schou, Peter van der Meer, Dragos Vinereanu, Shelley Zieroth, Martina Brueckmann, Mikhail Sumin, Deepak L. Bhatt, Adrian F. Hernandez, Stefan D. Anker   +23 more
wiley   +1 more source

Dipeptidyl peptidase IV in angiotensin-converting enzyme inhibitor-associated angioedema

James Brian Byrd, Stephanie Harris, James S. Gainer, Chang Yu, Ajai Shreevatsa, Pradeep Putlur, Deleted Author ID, Karine Touzin, Marshall Summar, A. Adam, Nancy J. Brown   +10 more
openalex   +1 more source

Long-Term Combined Therapy with an Angiotensin Type I Receptor Blocker and an Angiotensin Converting Enzyme Inhibitor Prolongs Survival in Dilated Cardiomyopathy.

, 2002
Toshihiro Shimizu, Hiroshi Okamoto, Satoru Chiba, Yutaka Matsui, Takeshi Sugawara, Hisao Onozuka, Taisei Mikami, Hideki Kumamoto, Akira Kitabatake   +8 more
openalex   +2 more sources

Role of N-Acetyl-Seryl-Aspartyl-Lysyl-Proline in the Antifibrotic and Anti-Inflammatory Effects of the Angiotensin-Converting Enzyme Inhibitor Captopril in Hypertension [PDF]

, 2007
Hongmei Peng, Oscar A. Carretero, Tang-Dong Liao, Edward L. Peterson, Nour-Eddine Rhaleb   +4 more
openalex   +1 more source

Withholding vs. continuing angiotensin-converting enzyme inhibitors or angiotensin receptor blockers before surgery: a systematic review and meta-analysis of randomized controlled trials. [PDF]

Ann Med
Dou W, Hu JH, Long YQ, Liu H, Ji FH, Sudhan N, Peng K.   +6 more
europepmc   +1 more source

Angiotensin receptor blockers, but not angiotensin-converting enzyme inhibitors, inhibit abnormal bone changes in spondyloarthritis. [PDF]

Exp Mol Med, 2023
Choi JS, Kim JY, Ahn MJ, Jang H, Song S, Choi SH, Park YS, Jo S, Kim TH, Shim SC.   +9 more
europepmc   +1 more source

A prospective analysis of management and outcomes of worsening heart failure in the outpatient setting

ESC Heart Failure, EarlyView.
Abstract Aims There is growing recognition of the burden and prognostic significance of WHF treated in the outpatient setting. However, there is currently a lack of prospective real‐world data in this area of HF care. This study aims to analyse the natural history of outpatient WHF.
Joseph McCambridge, Fiyinfoluwa Fabamwo, Shadia Taha, Dermot McCaffrey, Matthew Barrett, Ciara Mahon, Kenneth McDonald   +6 more
wiley   +1 more source

Identification of C-phycocyanin-derived Peptides as Angiotensin Converting Enzyme and Dipeptidyl Peptidase IV Inhibitors via Molecular Docking and Molecular Dynamic Simulation [PDF]

, 2020
Fei Pan, Na Zhou, Jiaxing Li, Xiaojing Du, Lei Zhao, Chengtao Wang, Mingxin Zhang, Xin Ai   +7 more
openalex   +1 more source

Prognostic impact of angiotensin-converting enzyme inhibitors and dexmedetomidine in acute respiratory distress syndrome: a MIMIC-IV-based retrospective cohort analysis. [PDF]

Front Med (Lausanne)
Hong Q, Yang X, Yang H, Zhou X, Tang J, Wen Z.   +5 more
europepmc   +1 more source